Two Sigma Investments’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,800
Closed -$5.51M 4034
2021
Q4
$5.51M Buy
20,800
+15,700
+308% +$4.23M 0.01% 1143
2021
Q3
$1.47M Sell
5,100
-6,100
-54% -$1.56M ﹤0.01% 2259
2021
Q2
$2.24M Buy
11,200
+10,000
+833% +$1.94M 0.01% 1768
2021
Q1
$233K Buy
+1,200
New +$246K ﹤0.01% 3527
2020
Q4
Sell
-2,500
Closed -$369K 3686
2020
Q3
$369K Buy
+2,500
New +$357K ﹤0.01% 2454

Other funds holding RGEN

Two Sigma Investments's RGEN Position: Q1 2026 in Review

Two Sigma Investments sold out of Repligen (RGEN) in Q1 2026, closing a stake of 8,400 shares — an estimated $1.38M sold.

Two Sigma Investments first reported a position in RGEN in Q2 2013 and held it in 31 quarters. The position peaked at $64.9M in Q3 2024. 443 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Two Sigma Investments reported no remaining Repligen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Investments sold 8,400 Repligen shares in Q1 2026, an estimated $1.38M.
  • Two Sigma Investments first reported a position in Repligen in Q2 2013 and held it in 31 quarters.
  • Two Sigma Investments's Repligen position peaked at $64.9M in Q3 2024.
  • 443 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.